Figure 1.
Time to disability worsening up to Year 7 confirmed for 12 (a) and 24 (b) weeks in BVL groupsa (Baseline to Year 2).
aAnalyses based on pooled data from placebo and active treatment groups (total population); Group 1 (least BVL): ⩽0.52% reduction; Group 2 (intermediate BVL): >0.52% to 2.18% reduction; Group 3 (most BVL): >2.18% reduction.
BVL: brain volume loss.